Arthritis und Rheuma, Inhaltsverzeichnis Arthritis und Rheuma 2017; 37(03): 196-199DOI: 10.1055/s-0037-1618426 Kinderrheumatologie/Kasuistik Schattauer GmbH Systemische JIA mit Polyarthritis nach einer Kawasaki-Erkrankung J. Peitz 1 Kinderrheumazentrum Asklepios Klinik St. Augustin, St. Augustin , G. Horneff 1 Kinderrheumazentrum Asklepios Klinik St. Augustin, St. Augustin› InstitutsangabenArtikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Neudorf U, Lilienthal E, Hospach T. Handlungsempfehlung nach der Leitlinie „Vaskulitiden - Kawasaki-Syndrom“. Monatszeitschrift Kinderheilkunde 2014; 162: 435-437. 2 Dong S, Bout-Tabaku S, Texter K, Jaggi P. Diagnosis of Systemic-Onset Juvenile Idiopathic Arthritis after Treatment for Presumed Kawasaki Disease. J Pediatr 2015; 166: 1283-1288. 3 Takahara T, Shimizu M, Nakagishi Y. et al. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease; Rheumatol Int. 2015; 35: 81-84. 4 Kudela H, Drynda S, Lux A. et al. Interleukin-18 (IL-18) as a Biomarker for Diagnosis and Evaluation of Disease Activity in Patients with Adult Onset Still’s Disease and Systemic Onset Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2015. 67: (suppl 10) 5 Wittkowski H, Frosch M, Foell D. S100A12 is a Novel Molecular Marker Differentiating Systemic Onset Juvenile Idiopathic Arthritis from other Causes of Fever of Unknown Origin. Arthritis Rheum 2008; 58 (12) 3924-3931. 6 Holzinger D, Frosch M, Kastrup A. et al. The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis 2012; 71 (06) 974-980.
